Clinuvel Pharmaceuticals Ltd. (CUVL)
6.01
-0.51
(-7.82%)
USD |
NASDAQ |
Sep 08, 16:00
6.07
+0.06
(+1.00%)
Pre-Market: 20:00
Clinuvel Pharmaceuticals Price : 6.01 for Sept. 8, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 08, 2026 | 6.10 | 6.19 | 6.00 | 6.01 | 51470.00 |
| Sep 04, 2026 | 6.29 | 6.733 | 6.10 | 6.52 | 79284.00 |
| Sep 03, 2026 | 6.30 | 6.400 | 6.19 | 6.28 | 22441.00 |
| Sep 02, 2026 | 6.25 | 6.40 | 6.20 | 6.20 | 34421.00 |
| Sep 01, 2026 | 6.06 | 6.600 | 6.05 | 6.24 | 44909.00 |
| Aug 31, 2026 | 6.00 | 6.53 | 5.95 | 5.95 | 42906.00 |
| Aug 28, 2026 | 6.56 | 6.56 | 6.12 | 6.16 | 51280.00 |
| Aug 27, 2026 | 7.39 | 7.960 | 6.760 | 6.77 | 30794.00 |
| Aug 26, 2026 | 7.80 | 7.80 | 7.644 | 7.644 | 1340.00 |
| Aug 25, 2026 | 8.10 | 8.10 | 7.60 | 7.60 | 14095.00 |
| Aug 24, 2026 | 8.00 | 8.20 | 7.42 | 7.42 | 26659.00 |
| Aug 21, 2026 | 7.80 | 7.80 | 7.80 | 7.80 | 206.00 |
| Aug 20, 2026 | 7.70 | 7.98 | 7.46 | 7.80 | 26407.00 |
| Aug 19, 2026 | 6.95 | 7.23 | 6.95 | 7.15 | 7675.00 |
| Aug 18, 2026 | 6.90 | 6.90 | 6.74 | 6.90 | 7173.00 |
| Aug 17, 2026 | 6.85 | 6.875 | 6.55 | 6.875 | 2805.00 |
| Aug 14, 2026 | 6.71 | 6.90 | 6.71 | 6.90 | 1644.00 |
| Aug 13, 2026 | 6.81 | 6.81 | 6.725 | 6.725 | 849.00 |
| Aug 12, 2026 | 6.90 | 6.90 | 6.600 | 6.68 | 2337.00 |
| Aug 11, 2026 | 6.72 | 6.86 | 6.70 | 6.86 | 2955.00 |
| Aug 10, 2026 | 6.74 | 6.74 | 6.74 | 6.74 | 290.00 |
| Aug 07, 2026 | 7.04 | 7.04 | 6.432 | 6.675 | 2843.00 |
| Aug 06, 2026 | 6.808 | 6.808 | 6.724 | 6.724 | 2867.00 |
| Aug 05, 2026 | 6.41 | 6.504 | 6.400 | 6.504 | 1650.00 |
| Aug 04, 2026 | 6.675 | 6.847 | 6.675 | 6.84 | 1231.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Alterity Therapeutics Ltd. | 4.51 |
| Kazia Therapeutics Ltd. | 12.01 |
| Algorae Pharmaceuticals Ltd. | 0.0096 |
| Immuron Ltd. | 1.84 |
| Amplia Therapeutics Ltd. | 0.10 |
Price Related Metrics
| PE Ratio | 13.07 |
| PS Ratio | 4.739 |
| PEG Ratio | 42.80 |
| Price to Free Cash Flow | 12.29 |
| Earnings Yield | 7.65% |
| Market Cap | 303.07M |
| PEGY Ratio | 14.50 |
| Operating PE Ratio | 10.90 |
| Normalized PE Ratio | 13.07 |